close

Fenwick Represents Bio-Rad in its Acquisition of RainDance Technologies

January 17, 2017

​​Fenwick & West represented Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, in its definitive agreement to purchase RainDance Technologies, Inc., a life science tools company. Financial terms of the transaction were not disclosed.

The acquisition will extend Bio-Rad’s reach into next generation sequencing applications and strengthen their position in the area of Droplet Digital PCR. 

The Fenwick transaction team included corporate lawyers Lynda Twomey, Maureen Montgomery, Jeremy Kazzaz and Shweta Kumar; executive compensation and employee benefits lawyers Gerald Audant and Elizabeth Gartland; intellectual property and technology transactions lawyers Stephen Gillespie and Michael Shuster; antitrust lawyer Mark Ostrau; litigation lawyer Melanie Mayer; and tax lawyers Andrew Kim and Michael Knobler.

​​